[1]
E. Abston, M. Moll, S. Hon, P. Govender, J. Berman, and H. Farber, “Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertensio”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 37, no. 2, pp. 184–191, Jun. 2020, doi: 10.36141/svdld.v37i2.9150.